Home Clinical Topics Endocrinology


A new technology may better help control type 1 diabetes

A recent study from The New England Journal of Medicine (NEJM) reveals a new system that has “improved glycemic outcomes in patients with type 1 diabetes.” The technology in question is a closed-loop system...

A potential change in the diagnosis of diabetes

A new article from Healthline reveals a potential change to the diagnosis of diabetes. Based on a study from Dr. Maria Mercedes Chang Villacreses at the City of Hope’s Diabetes and Metabolism Research Institute in...
gestational diabetes

Reducing barriers to glucose control in patients with gestational diabetes

According to the Centers for Disease Control and Prevention (CDC), 9.2% of pregnant women develop gestational diabetes mellitus (GDM) as a serious complication during pregnancy. A positive glucose tolerance test in the second trimester...
supplemental nutrition

Supplemental nutrition in hospitalized patients with diabetes

Continuing Nursing Education Learning objectives 1. Differentiate between enteral and parenteral nutrition. 2. Discuss how to manage hypoglycemia and hyperglycemia in patients with diabetes who are receiving supplemental nutrition. 3. Describe insulin use in patients...

Beware of oversimplifying mealtime insulin dosing for hospital patients

It’s lunchtime. Three of your patients are scheduled to receive rapid-acting insulin in addition to sliding-scale insulin. Mr. Jones, age 87, has type 2 diabetes. His blood glucose level is 223 mg/dL. He’s on...

Fear of the low: What you need to know about hypoglycemia

Approximately 25.8 million children and adults in the United States have diabetes. Especially with the diabetes rate rising yearly, you’re likely to care for many patients with this disorder. Of those diagnosed with diabetes, 80%...

FDA approves new drug for type 2 diabetes

On August 1, the U.S. Food and Drug Administration (FDA) approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Read more.

FDA approves Afrezza

On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Read more.

Study: Higher Hgb or receiving EPO doesn’t improve neuro outcomes in patients with TBI

In patients with a traumatic brain injury (TBI), the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin (Hgb) concentration through blood transfusion did not improve neurological outcome at 6 months, according...

FDA approves new hemophilia treatment

On June 6, the U.S. Food and Drug Administration (FDA) approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Read more.

At least 10% of MI patient may have undiagnosed diabetes

At least 10 percent of people who have a myocardial infarction (MI) may have undiagnosed diabetes, according to research presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2014....

Study: New drug effective for ACE-inhibitor angioedema

A Phase II study found that patients with ACE inhibitor-induced angioedema who received ecallantide were more likely to be discharged sooner than those treated with antihistamines and steroids. Read more.

Study: Chocolate’s flavanol could help prevent obesity

Oligomeric procyanidins (PCs), a type of flavanol in chocolate, could help reduce obesity, according to a study in Journal of Agricultural & Food Chemistry. Adding PCs to the food of mice that ate a...